These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 15993407)
1. Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract. Liu ES; Shin VY; Ye YN; Luo JC; Wu WK; Cho CH Eur J Pharmacol; 2005 Jul; 518(1):47-55. PubMed ID: 15993407 [TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091 [TBL] [Abstract][Full Text] [Related]
3. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Ye YN; Wu WK; Shin VY; Cho CH Eur J Pharmacol; 2005 Sep; 519(1-2):52-7. PubMed ID: 16125168 [TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Wang L; Chen W; Xie X; He Y; Bai X Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
8. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Sheng H; Shao J; Morrow JD; Beauchamp RD; DuBois RN Cancer Res; 1998 Jan; 58(2):362-6. PubMed ID: 9443418 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W; Yu CH; Hu KQ Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255 [TBL] [Abstract][Full Text] [Related]
10. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613 [TBL] [Abstract][Full Text] [Related]
11. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor. Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
13. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477 [TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin. Zhao S; Cai J; Bian H; Gui L; Zhao F Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877 [TBL] [Abstract][Full Text] [Related]
15. A mechanistic study of cigarette smoke and cyclooxygenase-2 on proliferation of gastric cancer cells. Shin VY; Liu ES; Ye YN; Koo MW; Chu KM; Cho CH Toxicol Appl Pharmacol; 2004 Feb; 195(1):103-12. PubMed ID: 14962510 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model. Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879 [TBL] [Abstract][Full Text] [Related]
17. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Abdelrahim M; Safe S Mol Pharmacol; 2005 Aug; 68(2):317-29. PubMed ID: 15883203 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]